<DOC>
	<DOCNO>NCT01139294</DOCNO>
	<brief_summary>The purpose study non-invasively study reflective change cardiac output response fluid therapy pediatric moderate hypovolemia/dehydrated pediatric patient use sub-q rehydration use Hylenex augment subcutaneous infusion fluid electrolyte compare intravenous method .</brief_summary>
	<brief_title>Descriptive Study Cardiac Output During Rehydration With Recombinant Human Hyaluronidase Pediatrics</brief_title>
	<detailed_description>This open-labeled , single-center Phase IV clinical trial . The study consist patient moderate hypovolemia/dehydration require parenteral rehydration . It expect study describe onset change cardiac output use Hylenex augment subcutaneous rehydration age 2 month 3 year flow rate satisfy clinical need , especially reference change cardiac output observe standard intravenous rehydration .</detailed_description>
	<mesh_term>Dehydration</mesh_term>
	<criteria>patient present ED moderate dehydration ( gorelick dehydration classification : presence 36 moderate sign symptom ) require parenteral rehydration . Patient successfully receive oral IV fluid immediately prior enrollment patient 's legally authorize representative sign informed consent willing patient receive Hylenex augment subq rehydration patient shock lifethreatening situation immunocompromised , history abscess cellulitis , abscess &amp; /or cellulitis cause MRSA , family history abscess cellulitis require IV therapy another indication indwell catheter already receive rehydration therapy IV route within last 48 hour substantial oral fluid immediate time period enrollment condition preclude subq injection infusion site evaluation upper middle back area another elect site infusion reason hospital admission extend ED stay dehydration know hypersensitivity hyaluronidase another ingredient formulation Hylenex know hyponatremia &lt; 130 mEq/L hypernatremia &gt; 155 mEq/L know hypokalemia &lt; 3.0 mEq/L medical condition likely interfere patient ability fully complete study protocol ability protocolspecified assessment medical history , screen physical exam find historical clinical lab result opinion investigator would preclude patient safe participation study might adversely effect interpretation study result patient participate study investigational drug device within 230 day prior enrollment study</criteria>
	<gender>All</gender>
	<minimum_age>2 Months</minimum_age>
	<maximum_age>3 Years</maximum_age>
	<verification_date>June 2010</verification_date>
	<keyword>cardiac output</keyword>
	<keyword>dehydration</keyword>
	<keyword>pediatrics</keyword>
</DOC>